Skip to content

Performance of a New Glucose Meter System in Children and Young Adults

Performance of the DIDGET Blood Glucose Monitoring System in Children and Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00985257
Enrollment
123
Registered
2009-09-28
Start date
2009-09-30
Completion date
2009-10-31
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study is to evaluate the performance of a new blood glucose meter in the hands of children, teens, young adults.

Interventions

DEVICEDIDGET (Investigational Blood Glucose Monitoring System)

Subjects with diabetes (with parent/guardian assistance, if applicable)and health care professionals (HCPs) each performed duplicate Blood Glucose (BG) tests from the subject's capillary blood on the DIDGET. To test the full range of glucose concentrations, a venipuncture was performed on some subjects to obtain enough blood for modifying (spiking or glycolyzing) to the extreme glucose concentrations. Results were compared to a laboratory glucose method - the Yellow Springs Instrument (YSI) Analyzer.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 or Type 2 diabetes * Age 4 to 24 years * Routinely performs blood glucose testing at home * If age 18 or older at time informed consent is signed, subject must be able to speak, read, and understand English. * If younger than age 18, subject's parent/guardian must be able to speak, read, and understand English, and is able to provide appropriate supervision. * Is willing to complete all study procedures, with or without parent / guardian supervision, if appropriate

Exclusion criteria

* Currently pregnant * Hemophilia or any other bleeding disorder * Taking prescription anticoagulants (such as Warfarin or heparin) or has clotting problems that may prolong bleeding. Taking Plavix or aspirin daily is not excluded * Infection with a blood borne pathogen (e.g., HIV, hepatitis) * Subject or parent/guardian is employee of competitive medical device company * Cognitive disorder or other condition, which in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study

Design outcomes

Primary

MeasureTime frameDescription
Percent of Blood Glucose (BG) Results Within +/-15mg/dL or +/-20% of Laboratory Glucose Method1-2 hoursSubjects with diabetes and healthcare professionals (HCPs) used a new blood glucose monitoring system (BGMS) with subject blood. BGM results were compared to a lab glucose method - Yellow Springs Instrument (YSI) Analyzer. Duplicate BG results were used to calculate the number of BG results within +/-15mg/dL (for reference BG results \<75mg/dL) or +/- 20% (for reference BG values \>/=75mg/dL) of the reference method results.

Countries

United States

Participant flow

Participants by arm

ArmCount
Subjects With Diabetes
Subjects with diabetes (or parents/guardians, if applicable)and healthcare professionals (HCPs) use a new blood glucose monitoring system. Subjects were 4 to 24 years of age with type 1 and type 2 diabetes.
123
Total123

Baseline characteristics

CharacteristicSubjects With Diabetes
Age, Customized
Age 13 to 17 years
30 participants
Age, Customized
Age 18 to 24 years
52 participants
Age, Customized
Age 4-12 years
41 participants
Region of Enrollment
United States
123 participants
Sex: Female, Male
Female
69 Participants
Sex: Female, Male
Male
54 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 123
serious
Total, serious adverse events
0 / 123

Outcome results

Primary

Percent of Blood Glucose (BG) Results Within +/-15mg/dL or +/-20% of Laboratory Glucose Method

Subjects with diabetes and healthcare professionals (HCPs) used a new blood glucose monitoring system (BGMS) with subject blood. BGM results were compared to a lab glucose method - Yellow Springs Instrument (YSI) Analyzer. Duplicate BG results were used to calculate the number of BG results within +/-15mg/dL (for reference BG results \<75mg/dL) or +/- 20% (for reference BG values \>/=75mg/dL) of the reference method results.

Time frame: 1-2 hours

Population: To achieve glucose concentrations across the meter test range, 47 blood samples were modified. The total glucose distribution (total 121 natural capillary samples plus 47 modified) ranged from 25.7 to 563.5mg/dL. Two sets of subject results were not analyzed because sufficient sample was not obtained for the YSI reference test.

ArmMeasureGroupValue (NUMBER)
Subjects With DiabetesPercent of Blood Glucose (BG) Results Within +/-15mg/dL or +/-20% of Laboratory Glucose MethodSubject Tests Natural Capillary n=242=2 x 12197.1 percent of blood glucose results
Subjects With DiabetesPercent of Blood Glucose (BG) Results Within +/-15mg/dL or +/-20% of Laboratory Glucose MethodCombine Natural+Modified n=336=2 x (121+47)97.9 percent of blood glucose results

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026